🇺🇸 Annovera in United States

FDA authorised Annovera on 10 August 2018

Marketing authorisations

FDA — authorised 10 August 2018

  • Application: NDA209627
  • Marketing authorisation holder: MAYNE PHARMA
  • Local brand name: ANNOVERA
  • Indication: RING — VAGINAL
  • Status: approved

Read official source →

FDA

  • Marketing authorisation holder: MAYNE PHARMA
  • Status: approved

Annovera in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Annovera approved in United States?

Yes. FDA authorised it on 10 August 2018; FDA has authorised it.

Who is the marketing authorisation holder for Annovera in United States?

MAYNE PHARMA holds the US marketing authorisation.